1Wk·

Acquisition: Novo Nordisk

Today I purchased the second tranche of my $NOVO B (+1.6%) position. I’m currently planning one more purchase to build up my desired initial position. Once I’ve reached that level, I’ll continue to grow the position—like many of my investments—through a savings plan.

02.07
Novo Nordisk A/S Class B logo
Bought at €43.35
17
9 Comments

profile image
I've already filled my position with 400 shares. In my opinion, it's a worthwhile investment—if you're patient. …I also think we're seeing a strong bottom forming here now. …The price is now creeping upward very slowly.
3
profile image
@G_Capital I agree. You have to be willing to invest some time. But since I generally always try to invest for the long term, that works for me.
1
profile image
@DividendenPapa …we're going to have a lot of fun with this number!
1
@G_Capital I'd be up a solid 33% if I sold.

But yeah, in my opinion, it's still undervalued.

I bought it when the stock dropped to a single-digit P/E ratio and people here were calling the buyers crazy ;)
2
profile image
@MarkusF …it’s creeping very slowly toward 50. …once it hits 50, things start moving fast, in my opinion 😉
1
profile image
I've also bought 737 shares over the past few months and am already up 11%. Novo is definitely picking up steam again. It's part of my income portfolio.
1
profile image
But what about Dividend Papa Invest?
Do you see dividend yields here again in the future?
profile image
@Smudeo …the outlook looks good!
2
profile image
@Smudeo Good question. 😊 While the current dividend yield wasn’t the main reason for my purchase, I do think it’s actually quite attractive right now when viewed in a historical context. What’s much more important to me is that $NOVO B has historically shown a very strong dividend growth rate.
In the short term, dividend growth could be somewhat more moderate due to increasing competition. In the long term, however, I remain confident that the company will continue to generate rising profits and, consequently, further growing dividends. That’s exactly why $NOVO B fits well into my strategy, despite the current challenges.
3
Join the conversation